Becton, Dickinson & Co. (BDX)
207.11
-1.24
(-0.60%)
USD |
NYSE |
Jan 16, 16:00
205.52
-1.59
(-0.77%)
Pre-Market: 08:38
Becton, Dickinson EPS Diluted (Quarterly): 1.717 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| West Pharmaceutical Services, Inc. | 1.928 |
| Abbott Laboratories | 0.9146 |
| Boston Scientific Corp. | 0.5048 |
| Accuray, Inc. | -0.1822 |
| Insulet Corp. | 1.240 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 493.00M |
| Revenue (Quarterly) | 5.89B |
| Total Expenses (Quarterly) | 5.397B |
| Enterprise Value | 78.27B |
| Gross Profit Margin (Quarterly) | 47.50% |
| Profit Margin (Quarterly) | 8.37% |
| Earnings Yield | 2.81% |
| Operating Earnings Yield | 5.17% |
| Normalized Earnings Yield | -0.5359 |